Atara Biotherapeutics Inc
ATRAHealthcare|Biotechnology|USA
$9.72
-0.26 (-2.59%)
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (354)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nguyen AnhCo | President and CEO | 2026-05-18 | SELL | 5,241 | $9.13 | $47.9K |
| Grant-Huerta Yanina | Chief Accounting Officer | 2026-05-18 | SELL | 2,414 | $9.13 | $22K |
| EcoR1 Capital, LLC | 10% Owner | 2026-05-07 | BUY | 507,407 | $9.35 | $4744.3K |
| Panacea Innovation Ltd | 10% Owner | 2026-05-07 | SELL | 313,446 | $10.1 | $3165.8K |
| Grant-Huerta Yanina | Chief Accounting Officer | 2026-03-02 | SELL | 2,104 | $5.08 | $10.7K |
| Nguyen AnhCo | President and CEO | 2026-03-02 | SELL | 2,996 | $5.09 | $15.2K |
| Panacea Innovation Ltd | 10% Owner | 2026-01-12 | SELL | 80,554 | $6.07 | $489K |
| Nguyen AnhCo | President and CEO | 2025-11-17 | SELL | 2,915 | $13.19 | $38.4K |
| Grant-Huerta Yanina | Chief Accounting Officer | 2025-11-17 | SELL | 1,804 | $13.19 | $23.8K |
| Grant-Huerta Yanina | Chief Accounting Officer | 2025-08-18 | SELL | 1,809 | $11.61 | $21K |
| Nguyen AnhCo | President and CEO | 2025-08-18 | SELL | 2,958 | $11.62 | $34.4K |
| Panacea Innovation Ltd | 10% Owner | 2025-08-15 | BUY | 55,000 | $12.19 | $670.5K |
| Panacea Innovation Ltd | 10% Owner | 2025-07-17 | BUY | 19,335 | $9.64 | $186.4K |
| Grant-Huerta Yanina | Chief Accounting Officer | 2025-05-16 | SELL | 2,218 | $6.76 | $15K |
| Nguyen AnhCo | President and CEO | 2025-05-16 | SELL | 3,276 | $6.76 | $22.1K |
| Nguyen AnhCo | President and CEO | 2025-03-03 | SELL | 3,331 | $7 | $23.3K |
| Hyllengren Eric J | EVP, CFO and COO | 2025-03-03 | SELL | 1,211 | $7 | $8.5K |
| Henrich Jill | EVP, Chief Regulatory Officer | 2025-03-03 | SELL | 1,059 | $7 | $7.4K |
| Henrich Jill | EVP, Chief Regulatory Officer | 2024-11-18 | SELL | 1,000 | $11.2 | $11.2K |
| Hyllengren Eric J | EVP, CFO and COO | 2024-11-18 | SELL | 1,364 | $11.2 | $15.3K |
| Nguyen AnhCo | President and CEO | 2024-11-18 | SELL | 1,664 | $11.2 | $18.6K |
| Touchon Pascal | President and CEO | 2024-08-16 | SELL | 3,038 | $6.63 | $20.1K |
| Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | 2024-08-16 | SELL | 1,821 | $6.63 | $12.1K |
| Murugan Amar | EVP, Chief Legal Officer | 2024-08-16 | SELL | 1,158 | $6.63 | $7.7K |
| Hyllengren Eric J | EVP, CFO | 2024-08-16 | SELL | 1,070 | $6.63 | $7.1K |
| Henrich Jill | EVP, Global Head RA & Quality | 2024-08-16 | SELL | 963 | $6.63 | $6.4K |
| Touchon Pascal | President and CEO | 2024-05-16 | SELL | 3,260 | $15.5 | $50.5K |
| Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | 2024-05-16 | SELL | 1,716 | $15.5 | $26.6K |
| Murugan Amar | EVP, Chief Legal Officer | 2024-05-16 | SELL | 1,296 | $15.5 | $20.1K |
| Hyllengren Eric J | EVP, CFO | 2024-05-16 | SELL | 1,146 | $15.5 | $17.8K |
| Henrich Jill | EVP, Global Head RA & Quality | 2024-05-16 | SELL | 1,030 | $15.5 | $16K |
| Murugan Amar | EVP, Chief Legal Officer | 2024-03-04 | SELL | 402 | $18 | $7.2K |
| Hyllengren Eric J | EVP, CFO | 2024-03-04 | SELL | 267 | $18 | $4.8K |
| Henrich Jill | EVP, Global Head RA & Quality | 2024-03-04 | SELL | 155 | $18 | $2.8K |
| Touchon Pascal | President and CEO | 2024-03-04 | SELL | 994 | $18 | $17.9K |
| Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | 2024-03-04 | SELL | 430 | $18 | $7.7K |
| Touchon Pascal | President and CEO | 2023-11-16 | SELL | 816 | $9.75 | $8K |
| Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | 2023-11-16 | SELL | 354 | $9.75 | $3.5K |
| Murugan Amar | EVP, Chief Legal Officer | 2023-11-16 | SELL | 332 | $9.75 | $3.2K |
| Joshi Manher | EVP, Chief Medical Officer | 2023-11-16 | SELL | 491 | $9.75 | $4.8K |
| Hyllengren Eric J | SVP, CFO | 2023-11-16 | SELL | 478 | $9.75 | $4.7K |
| Henrich Jill | EVP, Global Head RA & Quality | 2023-11-16 | SELL | 131 | $9.75 | $1.3K |
| Gallagher Carol Giltner | Director | 2023-11-14 | BUY | 10,800 | $6.25 | $67.5K |
| HEIDEN WILLIAM K | Director | 2023-11-10 | BUY | 4,000 | $6.25 | $25K |
| DOBMEIER ERIC | Director | 2023-11-10 | BUY | 17,873 | $5.75 | $102.8K |
| Hyllengren Eric J | SVP, CFO | 2023-08-16 | SELL | 327 | $41.25 | $13.5K |
| Murugan Amar | EVP, Chief Legal Officer | 2023-08-16 | SELL | 347 | $41.25 | $14.3K |
| Touchon Pascal | President and CEO | 2023-08-16 | SELL | 1,231 | $41.25 | $50.8K |
| Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | 2023-08-16 | SELL | 605 | $41.25 | $25K |
| Joshi Manher | EVP, Chief Medical Officer | 2023-08-16 | SELL | 279 | $41.25 | $11.5K |
| Henrich Jill | EVP, Global Head RA & Quality | 2023-08-16 | SELL | 134 | $41.25 | $5.5K |
| Touchon Pascal | President and CEO | 2023-06-27 | SELL | 572 | $41.5 | $23.7K |
| Murugan Amar | EVP, Chief Legal Officer | 2023-05-16 | SELL | 336 | $51 | $17.1K |
| Banard Charlene A. | EVP, Chief Technical Officer | 2023-05-16 | SELL | 762 | $51 | $38.8K |
| Touchon Pascal | President and CEO | 2023-05-16 | SELL | 1,191 | $51 | $60.7K |
| Hyllengren Eric J | SVP, CFO | 2023-05-16 | SELL | 317 | $51 | $16.2K |
| Touchon Pascal | President and CEO | 2023-03-02 | SELL | 627 | $90.75 | $56.9K |
| Murugan Amar | SVP, GC & Secretary | 2023-03-02 | SELL | 169 | $90.75 | $15.3K |
| Koppikar Utpal | CFO | 2023-03-02 | SELL | 275 | $90.75 | $24.9K |
| Dupont Jakob | EVP, Head of R&D | 2023-03-02 | SELL | 203 | $90.75 | $18.4K |
| Koppikar Utpal | CFO | 2023-02-07 | SELL | 99 | $136.5 | $13.6K |
| Dupont Jakob | EVP, Head of R&D | 2022-11-16 | SELL | 174 | $112.25 | $19.5K |
| Touchon Pascal | President and CEO | 2022-11-16 | SELL | 624 | $112.25 | $70K |
| Murugan Amar | SVP, GC & Secretary | 2022-11-16 | SELL | 144 | $112.25 | $16.2K |
| Koppikar Utpal | CFO | 2022-11-16 | SELL | 250 | $112.25 | $28.1K |
| Touchon Pascal | President and CEO | 2022-08-16 | SELL | 592 | $126 | $74.6K |
| Dupont Jakob | EVP, Head of R&D | 2022-08-16 | SELL | 165 | $125.75 | $20.7K |
| Murugan Amar | SVP, GC & Secretary | 2022-08-16 | SELL | 137 | $125.75 | $17.3K |
| Koppikar Utpal | CFO | 2022-08-16 | SELL | 238 | $126 | $29.9K |
| Touchon Pascal | President and CEO | 2022-06-27 | SELL | 569 | $180 | $102.4K |
| Koppikar Utpal | CFO | 2022-06-08 | SELL | 234 | $140.75 | $33K |
| Murugan Amar | SVP, GC & Secretary | 2022-05-17 | SELL | 129 | $133 | $17.1K |
| Koppikar Utpal | CFO | 2022-05-17 | SELL | 223 | $133 | $29.7K |
| Dupont Jakob | EVP, Head of R&D | 2022-05-17 | SELL | 155 | $133 | $20.6K |
| Touchon Pascal | President and CEO | 2022-05-17 | SELL | 557 | $133 | $74K |
| Koppikar Utpal | CFO | 2022-03-01 | SELL | 151 | $246.5 | $37.1K |
| Dupont Jakob | EVP, Head of R&D | 2022-03-01 | SELL | 89 | $246.5 | $21.9K |
| Touchon Pascal | President and CEO | 2022-03-01 | SELL | 353 | $246.5 | $87K |
| Murugan Amar | SVP, GC & Secretary | 2022-03-01 | SELL | 103 | $246.5 | $25.4K |
| Dupont Jakob | EVP, Head of R&D | 2022-02-10 | SELL | 200 | $400 | $80K |
| Koppikar Utpal | CFO | 2022-02-07 | SELL | 100 | $361.5 | $36.1K |
| Dupont Jakob | EVP, Head of R&D | 2021-12-01 | SELL | 200 | $448.5 | $89.7K |
| Touchon Pascal | President and CEO | 2021-11-16 | SELL | 336 | $428 | $143.8K |
| Newell Joe | COO | 2021-11-16 | SELL | 133 | $428 | $57K |
| Murugan Amar | SVP, GC & Secretary | 2021-11-16 | SELL | 85 | $428 | $36.4K |
| Koppikar Utpal | CFO | 2021-11-16 | SELL | 146 | $428 | $62.6K |
| Dupont Jakob | EVP, Head of R&D | 2021-11-16 | SELL | 88 | $428 | $37.6K |
| Newell Joe | COO | 2021-11-15 | SELL | 280 | $442.75 | $124K |
| Fust Matthew K | Director | 2021-11-04 | SELL | 534 | $487.5 | $260.4K |
| Dupont Jakob | EVP, Head of R&D | 2021-11-02 | SELL | 200 | $410.25 | $82.1K |
| Newell Joe | COO | 2021-09-22 | SELL | 420 | $425 | $178.5K |
| Newell Joe | COO | 2021-09-15 | SELL | 125 | $390.25 | $48.6K |
| Newell Joe | COO | 2021-08-30 | SELL | 140 | $375 | $52.5K |
| Touchon Pascal | President and CEO | 2021-08-17 | SELL | 329 | $313.25 | $103K |
| Newell Joe | COO | 2021-08-17 | SELL | 97 | $313.25 | $30.4K |
| Murugan Amar | SVP, GC & Secretary | 2021-08-17 | SELL | 83 | $313.25 | $26.1K |
| Koppikar Utpal | CFO | 2021-08-17 | SELL | 143 | $313.25 | $44.8K |
| Dupont Jakob | EVP, Head of R&D | 2021-08-17 | SELL | 86 | $313.25 | $27K |
| Touchon Pascal | President and CEO | 2021-06-25 | SELL | 568 | $408 | $231.6K |
| Yarema Kristin | Chief Commercial Officer | 2021-06-14 | BUY | 1,374 | $364.25 | $500.5K |
| Koppikar Utpal | CFO | 2021-06-08 | SELL | 233 | $351.5 | $81.8K |
| Newell Joe | COO | 2021-05-18 | SELL | 98 | $363.75 | $35.7K |
| Dupont Jakob | EVP, Head of R&D | 2021-05-18 | SELL | 207 | $363.75 | $75.4K |
| Murugan Amar | SVP, GC & Secretary | 2021-05-18 | SELL | 227 | $363.75 | $82.7K |
| Touchon Pascal | President and CEO | 2021-05-18 | SELL | 333 | $363.75 | $121K |
| Koppikar Utpal | CFO | 2021-05-18 | SELL | 145 | $363.75 | $52.6K |
| Yarema Kristin | Chief Commercial Officer | 2021-05-18 | SELL | 30 | $363.75 | $11.1K |
| Newell Joe | COO | 2021-04-05 | SELL | 26 | $368.5 | $9.7K |
| Koppikar Utpal | CFO | 2021-03-26 | SELL | 70 | $364.5 | $25.7K |
| Newell Joe | COO | 2021-03-26 | SELL | 106 | $364.5 | $38.5K |
| Newell Joe | COO | 2021-03-15 | SELL | 280 | $435.25 | $121.9K |
| Newell Joe | COO | 2021-03-02 | SELL | 67 | $418.5 | $27.9K |
| Koppikar Utpal | CFO | 2021-03-02 | SELL | 58 | $418.5 | $24.5K |
| Touchon Pascal | President and CEO | 2021-03-02 | SELL | 195 | $418.5 | $81.8K |
| Koppikar Utpal | CFO | 2021-02-08 | SELL | 70 | $509.75 | $35.9K |
| Newell Joe | COO | 2021-02-08 | SELL | 155 | $509.75 | $79.2K |
| Newell Joe | COO | 2021-01-15 | SELL | 280 | $471 | $131.9K |
| Newell Joe | COO | 2020-12-16 | SELL | 280 | $577.75 | $161.8K |
| Koppikar Utpal | CFO | 2020-11-17 | SELL | 59 | $494.25 | $29K |
| Newell Joe | COO | 2020-11-17 | SELL | 66 | $494.25 | $32.6K |
| Touchon Pascal | President and CEO | 2020-11-17 | SELL | 189 | $494.25 | $93.2K |
| Newell Joe | COO | 2020-11-13 | SELL | 300 | $462.25 | $138.7K |
| Touchon Pascal | President and CEO | 2020-08-18 | SELL | 192 | $302.25 | $58.1K |
| Koppikar Utpal | CFO | 2020-08-18 | SELL | 60 | $302.25 | $18.1K |
| Newell Joe | COO | 2020-08-18 | SELL | 67 | $302.25 | $20.3K |
| Touchon Pascal | President and CEO | 2020-06-25 | SELL | 485 | $323 | $156.8K |
| Koppikar Utpal | CFO | 2020-06-09 | SELL | 157 | $254.5 | $39.9K |
| Newell Joe | COO | 2020-05-18 | SELL | 64 | $280.5 | $18K |
| Koppikar Utpal | CFO | 2020-05-18 | SELL | 57 | $280.5 | $16K |
| Touchon Pascal | President and CEO | 2020-05-18 | SELL | 128 | $280.5 | $35.8K |
| Newell Joe | COO | 2020-04-06 | SELL | 26 | $198.5 | $5.2K |
| Koppikar Utpal | CFO | 2020-03-27 | SELL | 73 | $229.25 | $16.8K |
| Newell Joe | COO | 2020-03-27 | SELL | 110 | $229.25 | $25.1K |
| Newell Joe | Chief Tech. Operations Officer | 2020-02-06 | SELL | 165 | $355.25 | $58.5K |
| Koppikar Utpal | CFO | 2020-02-06 | SELL | 71 | $355.25 | $25.3K |
| Newell Joe | Chief Tech. Operations Officer | 2019-09-27 | SELL | 140 | $337.75 | $47.3K |
| DOBMEIER ERIC | Director | 2019-06-27 | BUY | 80 | $487.5 | $39K |
| Ciechanover Isaac E. | CEO | 2019-05-30 | SELL | 234 | $577.25 | $135.1K |
| Ciechanover Isaac E. | CEO | 2019-05-14 | SELL | 312 | $615.25 | $192K |
| Newell Joe | Chief Tech. Operations Officer | 2019-05-06 | SELL | 60 | $875 | $52.5K |
| Ciechanover Isaac E. | CEO | 2019-04-26 | SELL | 312 | $838.5 | $261.6K |
| Ciechanover Isaac E. | CEO | 2019-04-11 | SELL | 312 | $916.5 | $285.9K |
| Newell Joe | Chief Tech. Operations Officer | 2019-04-01 | SELL | 60 | $999 | $59.9K |
| Ciechanover Isaac E. | CEO | 2019-03-29 | SELL | 312 | $966.5 | $301.5K |
| MARCUS JOEL S | Director | 2019-03-15 | SELL | 800 | $956.25 | $765K |
| Ciechanover Isaac E. | CEO | 2019-03-15 | SELL | 312 | $987 | $307.9K |
| Newell Joe | Chief Tech. Operations Officer | 2019-03-01 | SELL | 60 | $903.25 | $54.2K |
| Ciechanover Isaac E. | CEO | 2019-02-28 | SELL | 312 | $903.5 | $281.9K |
| MARCUS JOEL S | Director | 2019-02-28 | SELL | 2,504 | $901.75 | $2257.6K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2019-02-15 | SELL | 31 | $989.75 | $30.7K |
| Porter Derrell | SVP, Head of Global Commercial | 2019-02-15 | SELL | 236 | $1000 | $236.4K |
| Ciechanover Isaac E. | CEO | 2019-02-12 | SELL | 312 | $969.25 | $302.4K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2019-02-11 | SELL | 559 | $963.75 | $538.7K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2019-02-06 | SELL | 495 | $965.5 | $477.9K |
| Newell Joe | Chief Tech. Operations Officer | 2019-02-02 | SELL | 60 | $950.25 | $57K |
| Newell Joe | Chief Tech. Operations Officer | 2019-02-01 | SELL | 20 | $961 | $19.2K |
| Ciechanover Isaac E. | CEO | 2019-01-24 | SELL | 312 | $876.5 | $273.5K |
| Ciechanover Isaac E. | CEO | 2019-01-10 | SELL | 312 | $863.75 | $269.5K |
| Newell Joe | Chief Tech. Operations Officer | 2019-01-02 | SELL | 60 | $875 | $52.5K |
| Ciechanover Isaac E. | CEO | 2018-12-28 | SELL | 312 | $847 | $264.3K |
| Ciechanover Isaac E. | CEO | 2018-12-13 | SELL | 312 | $1066.5 | $332.7K |
| Newell Joe | Chief Tech. Operations Officer | 2018-12-03 | SELL | 60 | $1028.5 | $61.7K |
| Ciechanover Isaac E. | CEO | 2018-11-29 | SELL | 312 | $1009.75 | $315K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-11-15 | SELL | 31 | $845.25 | $26.2K |
| Ciechanover Isaac E. | CEO | 2018-11-15 | SELL | 312 | $865.5 | $270K |
| MARCUS JOEL S | Director | 2018-11-07 | SELL | 400 | $908.75 | $363.5K |
| Gallagher Carol Giltner | Director | 2018-11-07 | SELL | 855 | $909.5 | $777.6K |
| Newell Joe | Chief Tech. Operations Officer | 2018-11-01 | SELL | 60 | $875 | $52.5K |
| Ciechanover Isaac E. | CEO | 2018-10-23 | SELL | 312 | $848.75 | $264.8K |
| Ciechanover Isaac E. | CEO | 2018-10-05 | SELL | 312 | $1005.5 | $313.7K |
| Newell Joe | Chief Tech. Operations Officer | 2018-10-01 | SELL | 60 | $1032 | $61.9K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-09-26 | SELL | 540 | $1077 | $581.6K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-09-25 | SELL | 1,260 | $1004.25 | $1265.4K |
| Ciechanover Isaac E. | CEO | 2018-09-19 | SELL | 312 | $995.25 | $310.5K |
| Ciechanover Isaac E. | CEO | 2018-09-07 | SELL | 312 | $983.75 | $306.9K |
| Newell Joe | Chief Tech. Operations Officer | 2018-09-04 | SELL | 60 | $986.25 | $59.2K |
| Ciechanover Isaac E. | CEO | 2018-08-21 | SELL | 312 | $909.25 | $283.7K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-08-15 | SELL | 31 | $938.5 | $29.1K |
| Ciechanover Isaac E. | CEO | 2018-08-07 | SELL | 312 | $935.75 | $292K |
| Newell Joe | Chief Tech. Operations Officer | 2018-08-01 | SELL | 60 | $943.5 | $56.6K |
| Newell Joe | Chief Tech. Operations Officer | 2018-07-30 | SELL | 400 | $894.5 | $357.8K |
| Koppikar Utpal | CFO | 2018-07-27 | BUY | 80 | $920 | $73.6K |
| Ciechanover Isaac E. | CEO | 2018-07-27 | SELL | 312 | $950 | $296.4K |
| Ciechanover Isaac E. | CEO | 2018-07-10 | SELL | 2,336 | $1000 | $2336K |
| Ciechanover Isaac E. | CEO | 2018-06-27 | SELL | 256 | $990 | $253.4K |
| Gallagher Carol Giltner | Director | 2018-06-18 | SELL | 100 | $1119.5 | $112K |
| Ciechanover Isaac E. | CEO | 2018-06-06 | SELL | 352 | $1214 | $427.3K |
| Ciechanover Isaac E. | CEO | 2018-05-22 | SELL | 352 | $1293.5 | $455.3K |
| Clark Mitchall G. | EVP & Chief R & QA Officer | 2018-05-18 | SELL | 1,034 | $1250.75 | $1293.8K |
| Clark Mitchall G. | EVP & Chief R & QA Officer | 2018-05-16 | SELL | 186 | $1151.5 | $214K |
| Gallagher Carol Giltner | Director | 2018-05-16 | SELL | 11 | $1151.5 | $12.6K |
| Porter Derrell | SVP, Head of Global Commercial | 2018-05-15 | SELL | 653 | $1125.5 | $735.4K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-05-15 | SELL | 1,031 | $1132.5 | $1167.6K |
| Fust Matthew K | Director | 2018-05-14 | SELL | 491 | $1089.25 | $535.3K |
| Ciechanover Isaac E. | CEO | 2018-05-10 | SELL | 352 | $996.25 | $350.7K |
| Porter Derrell | SVP, Head of Global Commercial | 2018-05-08 | SELL | 62 | $1003.75 | $62K |
| Ciechanover Isaac E. | CEO | 2018-04-27 | SELL | 352 | $1061.5 | $373.6K |
| Ciechanover Isaac E. | CEO | 2018-04-12 | SELL | 352 | $1046.75 | $368.5K |
| Clark Mitchall G. | EVP & Chief R & QA Officer | 2018-03-29 | SELL | 896 | $1001.75 | $897.6K |
| Ciechanover Isaac E. | CEO | 2018-03-27 | SELL | 8 | $960 | $7.7K |
| Ciechanover Isaac E. | CEO | 2018-03-27 | SELL | 352 | $964.75 | $339.6K |
| Clark Mitchall G. | EVP & Chief R & QA Officer | 2018-03-27 | SELL | 4,008 | $946.75 | $3794.7K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-03-26 | SELL | 733 | $994.75 | $729.2K |
| MCGRATH JOHN | EVP & CFO | 2018-03-20 | SELL | 240 | $1010.25 | $242.5K |
| Ciechanover Isaac E. | CEO | 2018-03-16 | SELL | 352 | $1053.25 | $370.7K |
| Ciechanover Isaac E. | CEO | 2018-03-12 | SELL | 40 | $1157.75 | $46.3K |
| Ciechanover Isaac E. | CEO | 2018-02-22 | SELL | 712 | $1116.25 | $794.8K |
| Gallagher Carol Giltner | Director | 2018-02-16 | SELL | 47 | $1162.5 | $55K |
| MCGRATH JOHN | EVP & CFO | 2018-02-16 | SELL | 520 | $1176.75 | $611.9K |
| Ciechanover Isaac E. | CEO | 2018-02-16 | SELL | 800 | $1173 | $938.4K |
| Ciechanover Isaac E. | CEO | 2018-02-14 | SELL | 800 | $1170 | $936K |
| Turner Heather D | Former EVP, GC & Sec. | 2018-02-09 | SELL | 489 | $950.25 | $464.3K |
| Ciechanover Isaac E. | CEO | 2018-02-09 | SELL | 352 | $936 | $329.5K |
| Ciechanover Isaac E. | CEO | 2018-01-26 | SELL | 772 | $881.5 | $680.5K |
| Ciechanover Isaac E. | CEO | 2018-01-24 | SELL | 1,940 | $864.5 | $1677.1K |
| Ciechanover Isaac E. | CEO | 2018-01-16 | SELL | 24 | $759.5 | $18.2K |
| MCGRATH JOHN | EVP & CFO | 2018-01-12 | SELL | 1,480 | $608.75 | $901K |
| Ciechanover Isaac E. | CEO | 2018-01-12 | SELL | 1,148 | $534.75 | $613.9K |
| MCGRATH JOHN | EVP & CFO | 2017-12-29 | SELL | 1,280 | $500 | $640K |
| Ciechanover Isaac E. | CEO | 2017-12-29 | SELL | 888 | $457.25 | $406K |
| Ciechanover Isaac E. | CEO | 2017-12-13 | SELL | 176 | $366.25 | $64.5K |
| Ciechanover Isaac E. | CEO | 2017-11-30 | SELL | 176 | $356.25 | $62.7K |
| Soffer Gad | EVP & Chief Strategy Officer | 2017-11-17 | SELL | 280 | $375 | $105K |
| Clark Mitchall G. | EVP & Chief R & QA Officer | 2017-11-16 | SELL | 132 | $355 | $46.7K |
| Gallagher Carol Giltner | Director | 2017-11-16 | SELL | 47 | $355 | $16.8K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2017-11-15 | SELL | 64 | $334 | $21.4K |
| Ciechanover Isaac E. | CEO | 2017-11-14 | SELL | 176 | $336.75 | $59.3K |
| Ciechanover Isaac E. | CEO | 2017-10-27 | SELL | 176 | $339.75 | $59.8K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2017-10-16 | SELL | 240 | $358.75 | $86.1K |
| Ciechanover Isaac E. | CEO | 2017-10-12 | SELL | 176 | $375.5 | $66.1K |
| Ciechanover Isaac E. | CEO | 2017-09-20 | SELL | 176 | $388.5 | $68.4K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2017-09-15 | SELL | 240 | $382.5 | $91.8K |
| Ciechanover Isaac E. | CEO | 2017-09-07 | SELL | 176 | $375.5 | $66.1K |
| Ciechanover Isaac E. | CEO | 2017-08-23 | SELL | 176 | $338.5 | $59.6K |
| Gallagher Carol Giltner | Director | 2017-08-16 | SELL | 47 | $357.5 | $16.9K |
| Soffer Gad | EVP & Chief Strategy Officer | 2017-08-16 | SELL | 379 | $372 | $140.8K |
| MCGRATH JOHN | EVP & CFO | 2017-08-16 | SELL | 168 | $357.75 | $60.1K |
| Clark Mitchall G. | EVP & Chief R & QA Officer | 2017-08-16 | SELL | 121 | $358.25 | $43.3K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2017-08-15 | SELL | 304 | $368.75 | $112.2K |
| Ciechanover Isaac E. | CEO | 2017-08-11 | SELL | 176 | $366.75 | $64.5K |
| Ciechanover Isaac E. | CEO | 2017-07-25 | SELL | 220 | $412.25 | $90.7K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2017-07-17 | SELL | 240 | $373 | $89.5K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2017-06-15 | SELL | 240 | $316.25 | $75.9K |
| Gallagher Carol Giltner | Director | 2017-06-09 | SELL | 40 | $328.75 | $13.2K |
| Ciechanover Isaac E. | CEO | 2017-05-31 | SELL | 276 | $333.75 | $92.1K |
| Ciechanover Isaac E. | CEO | 2017-05-18 | SELL | 192 | $372.75 | $71.6K |
| MCGRATH JOHN | EVP & CFO | 2017-05-16 | SELL | 160 | $377.75 | $60.4K |
| Gallagher Carol Giltner | Director | 2017-05-16 | SELL | 47 | $381.25 | $18.1K |
| Clark Mitchall G. | EVP & Chief R & QA Officer | 2017-05-16 | SELL | 155 | $381.25 | $59.1K |
| Soffer Gad | EVP & Chief Strategy Officer | 2017-05-16 | SELL | 507 | $379 | $192.1K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2017-05-15 | SELL | 304 | $374.75 | $114K |
| Ciechanover Isaac E. | CEO | 2017-04-26 | SELL | 288 | $439 | $126.4K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2017-04-17 | SELL | 240 | $432 | $103.7K |
| Ciechanover Isaac E. | CEO | 2017-04-11 | SELL | 288 | $425.75 | $122.6K |
| Ciechanover Isaac E. | CEO | 2017-03-28 | SELL | 640 | $501.5 | $321K |
| MCGRATH JOHN | EVP & CFO | 2017-03-23 | SELL | 560 | $516.25 | $289.1K |
| Ciechanover Isaac E. | CEO | 2017-03-17 | SELL | 1,232 | $484.5 | $596.9K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2017-03-15 | SELL | 240 | $490 | $117.6K |
| Soffer Gad | EVP & Chief Strategy Officer | 2017-03-10 | SELL | 100 | $500 | $50K |
| MCGRATH JOHN | EVP & CFO | 2017-03-10 | SELL | 960 | $500 | $480K |
| MCGRATH JOHN | EVP & CFO | 2017-02-21 | SELL | 360 | $378.5 | $136.3K |
| Gallagher Carol Giltner | Director | 2017-02-16 | SELL | 47 | $402.5 | $19K |
| Soffer Gad | EVP & Chief Strategy Officer | 2017-02-16 | SELL | 571 | $385.5 | $220.1K |
| Clark Mitchall G. | EVP & Chief R & QA Officer | 2017-02-16 | SELL | 122 | $399 | $48.8K |
| Ciechanover Isaac E. | CEO | 2017-02-16 | SELL | 192 | $389 | $74.7K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2017-02-15 | SELL | 304 | $387.25 | $117.8K |
| Soffer Gad | EVP & Chief Strategy Officer | 2017-02-10 | SELL | 251 | $386.75 | $97.1K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2017-02-09 | SELL | 559 | $386.5 | $216.1K |
| Turner Heather D | EVP, General Counsel & Sec. | 2017-02-09 | SELL | 489 | $393 | $192K |
| Ciechanover Isaac E. | CEO | 2017-02-03 | SELL | 192 | $341.5 | $65.6K |
| Ciechanover Isaac E. | CEO | 2017-01-18 | SELL | 240 | $356 | $85.4K |
| Haqq Christopher | EVP, R&D & Chief Scientific Of | 2017-01-17 | SELL | 240 | $356.75 | $85.6K |
| Ciechanover Isaac E. | CEO | 2017-01-06 | SELL | 336 | $422.25 | $141.9K |
| Ciechanover Isaac E. | CEO | 2016-12-23 | SELL | 192 | $380.5 | $73.1K |
| Haqq Christopher | Chief Medical Officer | 2016-12-15 | SELL | 240 | $385 | $92.4K |
| Ciechanover Isaac E. | CEO | 2016-12-07 | SELL | 288 | $448.25 | $129.1K |
| Ciechanover Isaac E. | CEO | 2016-11-23 | SELL | 480 | $458.5 | $220.1K |
| Haqq Christopher | Chief Medical Officer | 2016-11-21 | SELL | 283 | $446.25 | $126.2K |
| Soffer Gad | COO | 2016-11-17 | SELL | 59 | $460.25 | $27.2K |
| Gallagher Carol Giltner | Director | 2016-11-16 | SELL | 47 | $483.75 | $22.9K |
| Soffer Gad | COO | 2016-11-16 | SELL | 669 | $500 | $334.4K |
| Clark Mitchall G. | Chief R & QA Officer | 2016-11-16 | SELL | 120 | $488.25 | $58.5K |
| Haqq Christopher | Chief Medical Officer | 2016-11-15 | SELL | 64 | $498.75 | $32K |
| MCGRATH JOHN | CFO | 2016-11-11 | SELL | 200 | $496 | $99.2K |
| Ciechanover Isaac E. | CEO | 2016-10-27 | SELL | 192 | $345.25 | $66.3K |
| Ciechanover Isaac E. | CEO | 2016-10-14 | SELL | 192 | $399 | $76.6K |
| MCGRATH JOHN | CFO | 2016-10-12 | SELL | 200 | $436.75 | $87.4K |
| Ciechanover Isaac E. | CEO | 2016-09-28 | SELL | 480 | $521.75 | $250.4K |
| Ciechanover Isaac E. | CEO | 2016-09-16 | SELL | 288 | $484 | $139.4K |
| Ciechanover Isaac E. | CEO | 2016-08-23 | SELL | 384 | $558.25 | $214.4K |
| Soffer Gad | COO | 2016-08-16 | SELL | 214 | $560.25 | $120K |
| Haqq Christopher | Chief Medical Officer | 2016-08-15 | SELL | 54 | $558 | $30K |
| Ciechanover Isaac E. | CEO | 2016-07-21 | SELL | 384 | $552.75 | $212.3K |
| Ciechanover Isaac E. | CEO | 2016-07-08 | SELL | 384 | $572 | $219.6K |
| Ciechanover Isaac E. | CEO | 2016-06-24 | SELL | 384 | $531.5 | $204.1K |
| Ciechanover Isaac E. | CEO | 2016-06-08 | SELL | 480 | $513.25 | $246.4K |
| Ciechanover Isaac E. | CEO | 2016-05-26 | SELL | 288 | $442.25 | $127.4K |
| Gallagher Carol Giltner | Director | 2016-05-18 | SELL | 47 | $399 | $18.9K |
| Soffer Gad | COO | 2016-05-17 | SELL | 217 | $397.75 | $86.3K |
| MCGRATH JOHN | CFO | 2016-05-16 | SELL | 216 | $394.25 | $85.1K |
| Haqq Christopher | Chief Medical Officer | 2016-05-16 | SELL | 64 | $389.25 | $25K |
| Clark Mitchall G. | Chief R & QA Officer | 2016-05-16 | SELL | 166 | $378.75 | $62.9K |
| Ciechanover Isaac E. | CEO | 2016-04-26 | SELL | 52 | $503 | $26.2K |
| Ciechanover Isaac E. | CEO | 2016-04-12 | SELL | 528 | $510 | $269.5K |
| Ciechanover Isaac E. | CEO | 2016-04-01 | SELL | 48 | $500.75 | $23.8K |
| DOBMEIER ERIC | Director | 2016-03-17 | BUY | 120 | $346.5 | $41.6K |
| Gallagher Carol Giltner | Director | 2016-02-17 | SELL | 47 | $407.5 | $19.3K |
| Soffer Gad | COO | 2016-02-17 | SELL | 228 | $419.25 | $95.8K |
| Haqq Christopher | Chief Medical Officer | 2016-02-16 | SELL | 128 | $385.75 | $49.5K |
| Clark Mitchall G. | Chief R & QA Officer | 2016-02-16 | SELL | 166 | $383.75 | $63.7K |
| MCGRATH JOHN | CFO | 2016-02-16 | SELL | 240 | $387.25 | $92.9K |
| Ciechanover Isaac E. | CEO | 2016-01-14 | SELL | 96 | $505 | $48.5K |
| Ciechanover Isaac E. | CEO | 2015-12-31 | SELL | 96 | $650 | $62.4K |
| DOBMEIER ERIC | Director | 2015-12-16 | BUY | 100 | $550 | $55K |
| Ciechanover Isaac E. | CEO | 2015-12-15 | SELL | 96 | $561.5 | $53.9K |
| Ciechanover Isaac E. | CEO | 2015-12-04 | SELL | 160 | $936.25 | $149.8K |
| MCGRATH JOHN | CFO | 2015-11-30 | SELL | 240 | $1000 | $240K |
| Ciechanover Isaac E. | CEO | 2015-11-24 | SELL | 192 | $875.75 | $168.1K |
| Soffer Gad | COO | 2015-11-17 | SELL | 303 | $780.5 | $236.8K |
| Gallagher Carol Giltner | Director | 2015-11-17 | SELL | 47 | $777.5 | $36.8K |
| Clark Mitchall G. | Chief R & QA Officer | 2015-11-16 | SELL | 166 | $791.75 | $131.5K |
| Ciechanover Isaac E. | CEO | 2015-10-22 | SELL | 128 | $646.25 | $82.7K |
| Ciechanover Isaac E. | CEO | 2015-10-07 | SELL | 160 | $827 | $132.3K |
| Ciechanover Isaac E. | CEO | 2015-09-24 | SELL | 208 | $1074.75 | $223.5K |
| Ciechanover Isaac E. | CEO | 2015-09-11 | SELL | 208 | $1154 | $240K |
| Haqq Christopher | Chief Medical Officer | 2015-08-31 | SELL | 200 | $1049.75 | $210K |
| Ciechanover Isaac E. | CEO | 2015-08-28 | SELL | 208 | $981.25 | $204.1K |
| Gallagher Carol Giltner | Director | 2015-08-24 | SELL | 705 | $1058.5 | $746.1K |
| Gallagher Carol Giltner | Director | 2015-08-19 | SELL | 466 | $1219.5 | $567.8K |
| MCGRATH JOHN | CFO | 2015-08-18 | SELL | 240 | $1234.5 | $296.3K |
| Soffer Gad | COO | 2015-08-18 | SELL | 660 | $1244 | $820.5K |
| Clark Mitchall G. | Chief R & QA Officer | 2015-08-17 | SELL | 313 | $1154.75 | $361.6K |
| Haqq Christopher | Chief Medical Officer | 2015-08-17 | SELL | 64 | $1147.75 | $73.6K |
| Haqq Christopher | Chief Medical Officer | 2015-07-31 | SELL | 100 | $1385.75 | $138.6K |
| Ciechanover Isaac E. | CEO | 2015-07-31 | SELL | 208 | $1404.5 | $292.1K |
| Ciechanover Isaac E. | CEO | 2015-07-17 | SELL | 208 | $1517.75 | $315.7K |
| Haqq Christopher | Chief Medical Officer | 2015-07-15 | SELL | 100 | $1573.5 | $157.4K |
| Haqq Christopher | Chief Medical Officer | 2015-07-01 | SELL | 100 | $1292 | $129.2K |
| Ciechanover Isaac E. | CEO | 2015-07-01 | SELL | 208 | $1260.5 | $262.2K |
| Ciechanover Isaac E. | CEO | 2015-06-18 | SELL | 208 | $1368 | $284.5K |
| MCGRATH JOHN | CFO | 2015-06-15 | SELL | 400 | $1250 | $500K |
| Haqq Christopher | Chief Medical Officer | 2015-06-15 | SELL | 300 | $1160.5 | $348.2K |
| Ciechanover Isaac E. | CEO | 2015-06-05 | SELL | 256 | $1072.75 | $274.6K |
| Haqq Christopher | Chief Medical Officer | 2015-06-01 | SELL | 100 | $1036.75 | $103.7K |
| MCGRATH JOHN | CFO | 2015-05-29 | SELL | 400 | $1000 | $400K |
| Ciechanover Isaac E. | CEO | 2015-05-22 | SELL | 160 | $939 | $150.2K |
| Ciechanover Isaac E. | CEO | 2015-04-23 | SELL | 208 | $1534 | $319.1K |
| MARCUS JOEL S | Director | 2015-03-10 | BUY | 160 | $739.25 | $118.3K |
| Gallagher Carol Giltner | Director | 2015-02-18 | BUY | 440 | $450 | $198K |
| MARCUS JOEL S | Director | 2014-10-21 | BUY | 364 | $275 | $100K |
| DP VIII Associates, L.P. | 10% Owner | 2014-10-21 | BUY | 74 | $275 | $20.3K |
| Domain Partners VIII, L.P. | 10% Owner | 2014-10-21 | BUY | 9,926 | $275 | $2729.7K |
| Gallagher Carol Giltner | Director | 2014-10-21 | BUY | 727 | $275 | $200K |
| MARCUS JOEL S | Director | 2014-10-21 | BUY | 6,000 | $275 | $1650K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked